Effect of Ovariectomy and Genistein on Hepatic Mitochondrial Function.
- Author:
Young Min LEE
1
;
Myeong Ho JUNG
;
Yeon Sook LEE
;
Jihyun SONG
Author Information
1. Division of Metabolic Disease, Department of Biomedical Sciences, National Institute of Health, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
genistein;
mitochondrial protein density;
ovariectomy;
SDH;
COX
- MeSH:
Adipose Tissue;
Animals;
Body Weight;
Diet, High-Fat;
Electron Transport Complex IV;
Estradiol;
Estrogens;
Female;
Genistein*;
Humans;
Insulin;
Insulin Resistance;
Liver;
Menopause;
Mice;
Mitochondria;
Mitochondrial Proteins;
Ovariectomy*;
Phosphorylation;
PPAR gamma;
Prevalence;
Rats;
Rats, Sprague-Dawley;
RNA, Messenger;
Succinate Dehydrogenase;
Weights and Measures
- From:The Korean Journal of Nutrition
2004;37(9):786-793
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Women with menopause or rats with ovariectomy is associated with increased body weight, body fat and insulin resistance, which are components of metabolic syndrome. Increased prevalence of metabolic syndrome after menopause might be associated with mitochondrial dysfunction, since mitochondrial oxidative and phosphorylation activity is strongly correlated with insulin sensitivity. Although estradiol replacement prevents the metabolic syndrome, harmful effect of estradiol hampers the casual usage to prevent the metabolic syndrome. It has been reported that genistein has a mild estrogenic activity, decreases fat mass in mice and has an antidiabetic role in diabetic rats. Although insulin resistance is closely related to mitochondrial functions, there has not been yet any study in regard to the effect of dietary genistein on mitochondrial function in the insulin resistant female subjects induced by ovariectomy or similar situation. The present study investigated whether the supplementation of genistein in the high fat diet affected the mitochondrial function of high fat fed ovariectomized rats. Female Sprague Dawley rats (8 weeks old) were assigned to the following groups: sham-operated + high fat diet (S, n = 6); sham-operated + high fat diet with 0.1% genistein (S + G, n = 7); ovariectomized + high fat diet (OVX, n = 8); ovariectomized + high fat diet with 0.1% genistein (OVX + G, n = 8). Ovariectomy significantly increased body weight compared with S group. Genistein consumption in ovariectomized (OVX + G) rats decreased body weight gain compared with OVX rats. Liver weights were increased by ovariectomy. The hepatic mitochondrial protein density expressed as mg per g liver was lower in the OVX group than in the S group. However, OVX + G group showed the increased mitochondrial protein density similar to the level of S group. When mRNA levels of genes related to mitochondria such as peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) and cytochrome c oxidase subunit III (COX III) were measured, there were decreases in the mRNA levels of PGC-1 and COX III in S + G, OVX and OVX + G group. The activity of cytochrome c oxidase was not different between groups. We could observe the decrease in succinate dehydrogenase (SDH) activity per g liver in OVX rats. Genistein supplement increased SDH activity. In conclusion, genistein supplementation to the OVX rats enhanced mitochondrial function by increasing mitochondrial protein density and SDH activity. The improvement in mitochondrial function by genistein can contribute to the improvement in metabolic syndrome.
